Article

Current status of cortisol findings in post-traumatic stress disorder.

Psychiatry Department, Mount Sinai School of Medicine, One Gustave Levy Place, New York, NY 10029, USA.
Psychiatric Clinics of North America (Impact Factor: 2.13). 07/2002; 25(2):341-68, vii. DOI: 10.1016/S0193-953X(02)00002-3
Source: PubMed

ABSTRACT This article summarizes findings of hypothalamic-pituitary-adrenal axis alterations in post-traumatic stress disorder (PTSD) and evaluates likely reasons for the lack of agreement among published studies. Sources of variance caused by methodologic and interpretative differences are highlighted, but the disparate findings are explained as illustrating a more complex neuroendocrinology of PTSD than has previously been described.

0 Bookmarks
 · 
201 Views
  • Source
  • [Show abstract] [Hide abstract]
    ABSTRACT: Using overnight metyrapone and combined dexamethasone/metyrapone tests, hypothalamic–pituitary–adrenocortical (HPA) axis feedback regulation was characterised in 10 patients with post-traumatic stress disorder (PTSD) and 10 matched healthy comparison subjects. Significant treatment effects of both metyrapone and the combination of dexamethasone and metyrapone were observed for adrenocorticotropic hormone (ACTH), 11-deoxycortisol (11-DOC) and cortisol, but no differences between patients and comparison subjects emerged. Dose–response studies using metyrapone and glucocorticoid agonists are needed to further investigate HPA axis regulation in PTSD.
    European Neuropsychopharmacology 08/2004; 14(4):337-339. · 5.40 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The aim of this study was to determine whether there is increased responsiveness to corticosteroids in posttraumatic stress disorder (PTSD) by examining the differential effects of dexamethasone (DEX) on the inhibition of lysozyme activity.Methods60 mL of blood was withdrawn at 8:00 am, and mononuclear leukocytes were isolated from the blood of 26 men with, and 18 men without, PTSD. An aliquot of live cells was incubated with a series of concentrations of DEX to determine the rate of inhibition of lysozyme activity; a portion of cells was frozen for the determination of glucocorticoid receptors (GR).ResultsSubjects with PTSD showed evidence of a greater sensitivity to glucocorticoids as reflected by a significantly lower mean concentration (nmol/L) of dexamethasone at which 50% of lysozyme activity is inhibited (IC50-DEX) (PTSD+ = 4.9 ± .53; PTSD− group = 7.2 ± .64). The lysozyme IC50-DEX was significantly correlated with age at exposure to the first traumatic event in subjects with PTSD (r = .44, n = 26, p = .025). The number of cytosolic glucocorticoid receptors was also correlated with age at exposure to the focal traumatic event (r = −.44, n = 25, p = .03) in PTSD.Conclusions This is the first in vitro demonstration of an alteration in target tissue sensitivity to glucocorticoids in PTSD. The lower lysozyme IC50-DEX might be related to the risk factor of prior exposure to trauma.
    Biological Psychiatry 06/2004; 55(11):1110-1116. · 9.47 Impact Factor